Ruth En-Yeung Choa, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sebum | 2 | 2023 | 17 | 1.710 |
Why?
|
| Sebaceous Glands | 2 | 2023 | 42 | 1.120 |
Why?
|
| Interleukin-13 | 1 | 2023 | 371 | 0.790 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 2023 | 179 | 0.770 |
Why?
|
| Interleukin-4 | 1 | 2023 | 1110 | 0.700 |
Why?
|
| Adipose Tissue, White | 1 | 2021 | 363 | 0.620 |
Why?
|
| Cytokines | 3 | 2023 | 7239 | 0.610 |
Why?
|
| T-Lymphocytes | 2 | 2023 | 10049 | 0.320 |
Why?
|
| Skin | 1 | 2021 | 4422 | 0.300 |
Why?
|
| Iduronidase | 2 | 2016 | 31 | 0.260 |
Why?
|
| Mucopolysaccharidosis I | 2 | 2016 | 52 | 0.260 |
Why?
|
| Multiple Myeloma | 1 | 2023 | 5118 | 0.260 |
Why?
|
| Adaptive Immunity | 2 | 2021 | 721 | 0.250 |
Why?
|
| Lipogenesis | 1 | 2023 | 209 | 0.200 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2021 | 133 | 0.190 |
Why?
|
| Receptors, Cytokine | 1 | 2021 | 258 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 12154 | 0.170 |
Why?
|
| Yersinia pseudotuberculosis Infections | 1 | 2017 | 5 | 0.150 |
Why?
|
| Immunoglobulins | 1 | 2021 | 865 | 0.150 |
Why?
|
| Yersinia pseudotuberculosis | 1 | 2017 | 26 | 0.150 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2017 | 139 | 0.140 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2016 | 79 | 0.130 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2016 | 78 | 0.130 |
Why?
|
| Puberty, Delayed | 1 | 2015 | 121 | 0.120 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 1894 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2023 | 3285 | 0.100 |
Why?
|
| Interferon-gamma | 1 | 2019 | 3128 | 0.090 |
Why?
|
| Homeostasis | 1 | 2021 | 3282 | 0.090 |
Why?
|
| Dependovirus | 1 | 2015 | 698 | 0.090 |
Why?
|
| Obesity | 2 | 2023 | 12802 | 0.090 |
Why?
|
| Immunity, Innate | 2 | 2019 | 3033 | 0.090 |
Why?
|
| Weight Loss | 1 | 2021 | 2649 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 3 | 2023 | 21724 | 0.090 |
Why?
|
| Glucose | 1 | 2021 | 4354 | 0.080 |
Why?
|
| Hypogonadism | 1 | 2015 | 790 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2015 | 1331 | 0.080 |
Why?
|
| Mice | 3 | 2023 | 80551 | 0.070 |
Why?
|
| Animals | 6 | 2023 | 166825 | 0.060 |
Why?
|
| Diet | 1 | 2021 | 7950 | 0.050 |
Why?
|
| Transgenes | 2 | 2016 | 999 | 0.050 |
Why?
|
| Apoptosis | 1 | 2017 | 9436 | 0.050 |
Why?
|
| Melanoma | 1 | 2019 | 5620 | 0.050 |
Why?
|
| Dogs | 2 | 2016 | 3840 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2021 | 23235 | 0.050 |
Why?
|
| Humans | 7 | 2023 | 752810 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2019 | 793 | 0.040 |
Why?
|
| Risk Factors | 1 | 2023 | 73418 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 800 | 0.030 |
Why?
|
| Genetic Vectors | 2 | 2016 | 3354 | 0.030 |
Why?
|
| Receptors, Tachykinin | 1 | 2015 | 25 | 0.030 |
Why?
|
| Models, Immunological | 1 | 2017 | 505 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13173 | 0.030 |
Why?
|
| Tachykinins | 1 | 2015 | 77 | 0.030 |
Why?
|
| Sulfotransferases | 1 | 2015 | 149 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 241 | 0.030 |
Why?
|
| Receptors, Peptide | 1 | 2015 | 276 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2016 | 608 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14296 | 0.030 |
Why?
|
| Transfection | 1 | 2019 | 5783 | 0.020 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2015 | 827 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 6112 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2017 | 1480 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 2174 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2015 | 1204 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 2659 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 217168 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 1440 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2017 | 2471 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2015 | 2306 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 1229 | 0.020 |
Why?
|
| Pedigree | 1 | 2015 | 4573 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 17960 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2015 | 4112 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 4218 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4502 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 10187 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 16739 | 0.010 |
Why?
|
| Macrophages | 1 | 2017 | 5690 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4411 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40996 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13558 | 0.010 |
Why?
|
| Female | 3 | 2019 | 386339 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 86822 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2015 | 79160 | 0.000 |
Why?
|
| Male | 1 | 2015 | 355160 | 0.000 |
Why?
|